Literature DB >> 19352133

The effect of graft-versus-host disease on skin endothelial and epithelial cell chimerism in stem-cell transplant recipients.

Annemieke J Willemze1, Astrid C Bakker, Peter A von dem Borne, Ingeborg M Bajema, Jaak M Vossen.   

Abstract

BACKGROUND: Recent evidence indicates that bone marrow-derived cells contribute to endothelial and epithelial cell renewal in recipients of an allogeneic stem-cell transplantation (SCT). Controversy remains on the biological significance of these donor-derived cells.
METHODS: This study investigated the occurrence of endothelial and epithelial cell chimerism in relation to the conditioning regimen, time interval after SCT, and development of acute and chronic graft-versus-host disease (GVHD). Fifty-five skin biopsy samples from 35 female patients transplanted with a male donor were screened for donor-derived endothelial and epithelial cells using in situ hybridization for Y chromosomes in combination with immunohistochemical cell-marking techniques.
RESULTS: Endothelial cell chimerism was found in 25% of the biopsies and increased in time after SCT. Its appearance was increased in patients with acute GVHD more than 2 weeks before biopsy. Epithelial cell chimerism was found in 85% of the biopsies. Appearance of epithelial cell chimerism was not correlated with the time interval after SCT or with tissue damage caused by GVHD.
CONCLUSION: From these results, we conclude that donor-derived endothelial cell chimerism results from repair of damaged endothelium and maintenance of vascular homeostasis. In contrast, epithelial cell chimerism follows a more uniform pattern of engraftment, not influenced by tissue damage.

Entities:  

Mesh:

Year:  2009        PMID: 19352133     DOI: 10.1097/TP.0b013e31819d340f

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Persistence of recipient-type endothelium after allogeneic hematopoietic stem cell transplantation.

Authors:  Regula J Mueller; Georg Stussi; Gisella Puga Yung; Milica Nikolic; Davide Soldini; Jörg Halter; Sandrine Meyer-Monard; Alois Gratwohl; Jakob R Passweg; Bernhard Odermatt; Urs Schanz; Barbara C Biedermann; Jörg D Seebach
Journal:  Haematologica       Date:  2010-10-07       Impact factor: 9.941

2.  Graft-versus-host disease-associated angiomatosis: a clinicopathologically distinct entity.

Authors:  Benjamin H Kaffenberger; Rena C Zuo; Alejandro Gru; Alisha N Plotner; Sarah A Sweeney; Steven M Devine; Sharon R Hymes; Edward W Cowen
Journal:  J Am Acad Dermatol       Date:  2014-07-01       Impact factor: 11.527

3.  A donor thrombomodulin gene variation predicts graft-versus-host disease development and mortality after bone marrow transplantation.

Authors:  Haruka Nomoto; Akiyoshi Takami; J Luis Espinoza; Keitaro Matsuo; Shohei Mizuno; Makoto Onizuka; Koichi Kashiwase; Yasuo Morishima; Takahiro Fukuda; Yoshihisa Kodera; Noriko Doki; Koichi Miyamura; Takehiko Mori; Shinji Nakao; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2015-08-06       Impact factor: 2.490

4.  Isolated extramedullary cutaneous relapse despite concomitant severe graft-vs.-host disease and tissue chimerism analysis in a patient with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: A case report.

Authors:  Bulent Kantarcioglu; Huseyin Saffet Bekoz; Yeliz Duvarci Ogret; Asli Cakir; Demet Kivanc; Fatma Savran Oguz; Deniz Sargin
Journal:  Mol Clin Oncol       Date:  2016-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.